1st Quarter - Report

NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2025 and FY 2026 Appropriations for organ donation and transplantation activities (HRSA). FY 2025 and FY 2026 Appropriations for CDC Chronic Kidney Disease Initiative. FY 2025 and FY 2026 Appropriations for kidney research at the National Institute of Diabetes and Digestive and Kidney Diseases. FY 2025 and FY 2026 Appropriations for Indian Health Service.

LobbyistCovered position, as disclosed
LAUREN DREW —
TROY ZIMMERMAN —

Contacted: Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Indian Health Service; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES

Health Issues HCR

Activities to increase, improve and facilitate organ donation and transplantation, including the Honor our Living Donors Act (H.R. 628, S. 957) and the Living Donor Protection Act (to be introduced). Implementation of P.L. 118-14, "Securing the U.S. Organ Procurement and Transplantation Network Act." Implementation of the Advancing American Kidney Health Initiative. Support for telemedicine and telehealth access. Activities in support of access to affordable, accessible health care. Comments on the Organ Procurement and Transplantation Networks Kidney Transplantation Committee regarding the Continuous Distribution (CD) of kidneys project. Comments on the Monitor Ongoing eGFR Modification Policy Requirements from the Organ Procurement and Transplantation Networks Minority Affairs Committee.

LobbyistCovered position, as disclosed
LAUREN DREW —
MIRIAM ELIZABETH GODWIN —
MORGAN REID —
JESSE ROACH —
TROY ZIMMERMAN —

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 628 (119th), S. 957 (119th)

Medicare/Medicaid MMM

Initiatives to expand access to home dialysis. Medicare coverage of anti-obesity medications. Support for Medicare Part D Protected Classes. Access to Medicaid. Implementation of the Advancing American Kidney Health Initiative.

LobbyistCovered position, as disclosed
LAUREN DREW —
MIRIAM ELIZABETH GODWIN —
MORGAN REID —
JESSE ROACH —
TROY ZIMMERMAN —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.